{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:33:49Z","timestamp":1775068429604,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jchromb.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:02:44Z","timestamp":1465430564000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Simple and validated UHPLC\u2013MS\/MS analysis of nimodipine in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage"],"prefix":"10.1016","volume":"1028","author":[{"given":"Susan","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Contin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2016.06.012_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0303-8467(88)90005-4","article-title":"Nimodipine treatment of subarachnoid haemorrhage","volume":"90","author":"Laursen","year":"1988","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00228-007-0267-7","article-title":"Early-phase pharmacokinetics of enteral and parenteral nimodipine in patients with acute subarachnoid haemorrhage\u2014a pilot study","volume":"63","author":"Soppi","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0015","first-page":"84","article-title":"Enteral or parenteral nimodipine treatment: a comparative pharmacokinetic study","volume":"75","author":"Scheller","year":"2014","journal-title":"J. Neurol. Surg. A Cent. Eur. Neurosurg."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0020","doi-asserted-by":"crossref","first-page":"970741","DOI":"10.1155\/2014\/970741","article-title":"Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage","volume":"2014","author":"Ott","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-198937050-00004","article-title":"Nimodipine. A review of its pharmacodynamics and pharmacokinetic properties, and therapeutical potential in cerebrovascular disease","volume":"37","author":"Langley","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2016.06.012_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00701-015-2369-9","article-title":"Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage","volume":"157","author":"Abboud","year":"2015","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000346087","article-title":"European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"Steiner","year":"2013","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0040","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jchromb.2003.12.001","article-title":"Determination of nimodipine in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method","volume":"802","author":"Qiu","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2016.06.012_bib0050","first-page":"828","article-title":"Liquid chromatographic-electrospray tandem mass spectrometric method for the quantification of nimodipine in human plasma","volume":"61","author":"Nirogi","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.jchromb.2016.06.012_bib0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jpba.2007.10.035","article-title":"Determination of nimodipine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and pharmacokinetic application","volume":"46","author":"Qin","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/chromsci\/48.2.81","article-title":"Determination of nimodipine in human plasma by HPLC-ESI\u2013MS and its application to a bioequivalence study","volume":"48","author":"Zhao","year":"2010","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1590\/S1984-82502010000400008","article-title":"Determination of nimodipine in plasma by HPLC-MS\/MS and pharmacokinetic application","volume":"46","author":"do Nascimento","year":"2010","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0070","unstructured":"DURECT Corporation Preparation of artificial CSF, 2014. Available from http:\/\/alzet.com\/products\/guide_to_use\/cfs_preparation.html (last accessed 19.3.16)."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0075","unstructured":"EMEA\/CHMP\/EWP\/192217\/2009. Committee for Medicinal Products for Human Use (CHMP), Guideline on bioanalytical method validation (2011) 1\u201322."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0080","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0731-7085(00)00529-X","article-title":"Guidance for rubustness\/ruggedness tests in method validation","volume":"24","author":"Vander Heyden","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2016.06.012_bib0090","first-page":"474","article-title":"When should an internal standard be used?","volume":"30","author":"Dolan","year":"2012","journal-title":"LCGC North Am."},{"issue":"Suppl. 1","key":"10.1016\/j.jchromb.2016.06.012_bib0095","first-page":"74","article-title":"Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage","volume":"28","author":"Ramsch","year":"1985","journal-title":"Neurochirurgica (Stuttg.)"},{"key":"10.1016\/j.jchromb.2016.06.012_bib0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM198303173081103","article-title":"Cerebral arterial spasm\u2014a controlled trail of nimodipine in patients with subarachnoid hemorrhage","volume":"308","author":"Allen","year":"1983","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216303889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216303889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T07:31:01Z","timestamp":1572420661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023216303889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":20,"alternative-id":["S1570023216303889"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2016.06.012","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simple and validated UHPLC\u2013MS\/MS analysis of nimodipine in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}